Clinical and epidemiological characterization of COVID-19 in Camagüey
DOI:
https://doi.org/10.5281/zenodo.12762359Keywords:
covid-19, health profile, pandemics, sars-cov-2Abstract
Introduction: research on COVID-19 should be based on clinical and epidemiological data records, and the specific contexts of each region. This would make it possible to better identify the characteristics and consequences of the disease.
Objective: to analyze the clinical and epidemiological situation of COVID-19 in the Camagüey province from March to May 2020.
Methods: a cross-sectional descriptive study was carried out in the province of Camagüey during the first outbreak of the pandemic. The universe was made up of the 48 patients confirmed with the SARS-CoV-2 virus in this territory. The epidemiological information was obtained from the records of the Provincial Directorate of Public Health and the Provincial Center for Hygiene, Epidemiology and Microbiology. The daily reports on acute respiratory infections and the minutes of the technical meetings of the temporary working group for COVID-19 were taken into account. Ethical precepts were met.
Results: 37,50 % of the patients positive for the SARS-CoV-2 virus were between 40 and 59 years old and lived in the North (27,08 %), Central (18,75 %), North Florida (12,50 %), and Foresighted (10,42 %). 35,40 % of the cases were asymptomatic. The predominant symptoms were: cough (50,00 %), runny nose (35,40 %) and fever (29,20 %). Arterial hypertension was the most identified antecedent (19,00 %).
Conclusions: the results of this analysis are part of the historical memory of the pandemic stage in the territory. The research provided information to develop future research on the diseaseDownloads
References
Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg [Internet]. Abr 2020 [citado 12 Mar 2020];76:71-6. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105032/pdf/main.pdf
Vásquez-Rodríguez EP, Guadrón-Meléndez AA, Cruz-Aguilar RJ, Cuadra-Zelaya TE. Factores relevantes sobre el ensayo RT-PCR para la detección de SARS-CoV-2, virus causante del COVID-19. Alerta (San Salvador) [Internet]. 2021 [citado 22 Ene 2021];4(1):31-9. Disponible en: https://docs.bvsalud.org/biblioref/2021/01/1146454/factores_relevantes_sobre_el_ensayo_rt-pcr_para_la_deteccion_d_AucnkXH.pdf
Moreno-Contreras J, Espinoza MA, Sandoval-Jaime C, Cantú-Cuevas MA, Barón-Olivares H, Ortiz-Orozco OD, et al. Saliva sampling and its direct lysis, an excellent option to increase the number of SARS-CoV-2 diagnostic tests in settings with supply shortages. J Clin Microbiol [Internet]. 2020 [citado 1 Ago 2020];58(10):e01659-20. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512180/pdf/JCM.01659-20.pdf
Zhang H. Early lessons from the frontline of the 2019-nCoV outbreak. Lancet [Internet]. 2020 [citado 27 Jul 2020];395(10225):687. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135082/pdf/main.pdf
Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses [Internet]. Ene 2019 [citado 12 Mar 2020];11(1):59. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357155/pdf/viruses-11-00059.pdf
Paules CI, Marston HD, Fauci AS. Coronavirus infections more than just the common cold. JAMA [Internet]. 2020 [citado 23 Jun 2020];323(8):707-8. Disponible en: https://jamanetwork.com/journals/jama/articlepdf/2759815/jama_paules_2020_vp_200006.pdf
Calvo C, García-López-Hortelano M, De Carlos-Vicente JC, Vázquez-Martínez JL; Grupo de trabajo de la Asociación Española de Pediatría para el brote de infección por coronavirus, colaboradores con el Ministerio de Sanidad. Recomendaciones sobre el manejo clínico de la infección por el nuevo coronavirus SARS-CoV2. Grupo de trabajo de la Asociación Española de Pediatría (AEP). An Pediatr (Barc) [Internet]. Abr 2020 [citado 23 Jun 2020];92(4):241.e1-e11. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118614/pdf/main.pdf
Beldarraín-Chaple E, Alfonso-Sánchez IR, Morales-Suárez I, Durán García F. Primer acercamiento histórico-epidemiológico a la COVID-19 en Cuba. An Acad Cienc Cuba [Internet]. 2020 [citado 27 Jul 2020];10(2):[aprox. 8 p.]. Disponible en: http://revistaccuba.sld.cu/index.php/revacc/article/download/862/867
Mojica-Crespo R, Morales-Crespo MM. Pandemia COVID-19, la nueva emergencia sanitaria de preocupación internacional: una revisión. SEMERGEN, Soc. Esp. Med. Rural Gen. [Internet]. 46 Supl 1:72-84. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229959/pdf/main.pdf
Rothan HA, Byraredd SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19). J Autoimmun [Internet]. May 2020 [citado 29 Mar 2020];109:102433. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127067/pdf/main.pdf
Silva-Velazco AG, Dezoti-Da Fonseca C. Coronavírus 2020. Rev Bras Enferm [Internet]. Mar 2020 [citado 12 Mar 2020];73(2):e2020n2. Disponible en: https://www.scielo.br/j/estpsi/a/L6j64vKkynZH9Gc4PtNWQng/?format=pdf&lang=pt
Serra-Valdés MA. Infección respiratoria aguda por COVID-19: una amenaza evidente. Rev haban cienc méd [Internet]. Feb 2020 [citado 29 Mar 2020];19(1):1-5. Disponible en: http://scielo.sld.cu/pdf/rhcm/v19n1/1729-519X-rhcm-19-01-1.pdf
Cabrera-Gaytán DA, Vargas-Valerio A, Grajales-Muñiz C. Infección del nuevo coronavirus: nuevos retos, nuevos legados. Rev Med Inst Mex Seguro Soc [Internet]. 2014 [citado 29 Mar 2020];52(4):438-41. Disponible en: https://www.medigraphic.com/pdfs/imss/im-2014/im144r.pdf
Parra-Linares E, Lanio-Posada CA. Comportamiento epidemiológico de COVID-19 durante la fase inicial de la pandemia en Cuba. Medwave [Internet]. 2021 [citado 22 Ene 2021];21(1)e8111. Disponible en: https://www.medwave.cl/link.cgi/Medwave/Enfoques/ComunicacionesBreves/8111.act#
Asociación Médica Mundial. Declaración de Helsinki de la AMM. Principios éticos para las investigaciones médicas en seres humanos. Ratificada en la 64ª Asamblea General, Fortaleza, Brasil, octubre 2013. Helsinki: 18ª Asamblea Mundial; 1964 [citado 29 Mar 2020]. Disponible en: http://www.anmat.gov.ar/comunicados/HELSINSKI_2013.pdf
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020 [citado 12 Mar 2020];395(10223):497-506. Disponible en: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext
Guzmán-Del Giudice OE, Lucchesi-Vásquez EP, Trelles-De Belaúnde M, Pinedo-Gonzáles RH, Camere-Torrealva MA, Daly A, et al. Características clínicas y epidemiológicas de 25 casos de COVID-19 atendidos en la Clínica Delgado de Lima. Rev Soc Peru Med Interna [Internet]. Mar 2020 [citado 29 Mar 2020];33(1):15-24. Disponible en: https://www.researchgate.net/profile/Oscar-Guzman-8/publication/342507525_Caracteristicas_clinicas_y_epidemiologicas_de_25_casos_de_COVID-19_atendidos_en_la_Clinica_Delgado_de_Lima/links/5fe5ffb0a6fdccdcb8fe151c/Caracteristicas-clinicas-y-epidemiologicas-de-25-casos-de-COVID-19-atendidos-en-la-Clinica-Delgado-de-Lima.pdf
Acosta G, Escobar G, Bernaola G, Alfaro J, Taype W, Marcos C, et al. Caracterización de pacientes con COVID-19 grave atendidos en un hospital de referencia nacional del Perú. Rev. perú. med. exp. salud publica. [Internet] Jun 2020 [citado 29 Mar 2020];37(2):253-8. Disponible en: http://www.scielo.org.pe/pdf/rins/v37n2/1726-4642-rins-37-02-253.pdf
Porfirio-Da Silva D, Ramos-Dos Santos IM, Dos Santos-Melo V. Aspectos da infecção ocasionada pelo coronavírus da síndrome respiratória aguda grave 2 (SARS-CoV-2). Braz. J. Hea. Rev. [Internet]. 2020 [citado 29 Mar 2020];3(2):3763-79. Disponible en: https://www.brazilianjournals.com/index.php/BJHR/article/download/9304/7858
Candelaria-Brito JC, Díaz-Cruz SA, Acosta-Pérez DM, Junco-Sena B, Rodríguez-Méndez A. Primera comunidad en cuarentena por la COVID-19 de Cuba. Rev Ciencias Médicas [Internet]. Jun 2020 [citado 1 Ago 2020];24(3):e4485. Disponible en: http://scielo.sld.cu/pdf/rpr/v24n3/1561-3194-rpr-24-03-e4485.pdf
Ministerio de Salud Pública (Cuba). La Habana: MINSAP; c2020 [actualizado 5 Jun 2020; citado 19 Mar 2020] Parte de cierre del día 5 de junio a las 12 de la noche; [aprox. 4 pantallas]. Disponible en: https://salud.msp.gob.cu/parte-de-cierre-del-dia-5-de-junio-a-las-12-de-la-noche/
Cuello-Carballo MB, Díaz-Alfonso H, Cruz-Quesada JE, Carbó-Rodríquez HL, Dopico-Ravelo D. Caracterización clínico-epidemiológica de los pacientes confirmados con la COVID-19 en Pinar del Río. Rev Ciencias Médicas [Internet]. Oct 2020 [citado 12 Oct 2020];24(5):e4581. Disponible en: http://scielo.sld.cu/pdf/rpr/v24n5/1561-3194-rpr-24-05-e4581.pdf
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. [Internet]. 2020 [citado 29 Mar 2020];395(10223):507-13. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135076/pdf/main.pdf
Wolf DL, Lamster IB. Contemporary concepts in the diagnosis of periodontal disease. Dent Clin North Am. Ene 2011;55(1):47-61.
Gupta AK, Nethan ZT, Mehrotra R. Tobacco use as a well-recognized cause of severe COVID-19 manifestations. Respir Med [Internet]. Ene 2021 [citado 22 Ene 2021];176:106233. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674071/pdf/main.pdf
Ministerio de Salud Pública (Cuba). Protocolo Nacional MINSAP vs COVID-19. La Habana: MINSAP; 2020 [citado 29 Mar 2020]. Disponible en: https://covid19cubadata.github.io/protocolos/protocolo-version-2.pdf
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Marelys Cendra Asencio
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
